Cargando…
Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
BACKGROUND: Very early-onset inflammatory bowel disease (VEOIBD) with interleukin-10 (IL10R) signaling deficiency usually requires enterostomy in patients who are refractory to traditional treatment. This study aimed to evaluate long-term outcomes after enterostomy for VEOIBD patients with IL10R sig...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661559/ https://www.ncbi.nlm.nih.gov/pubmed/37986047 http://dx.doi.org/10.1186/s12876-023-03051-4 |
_version_ | 1785148470851534848 |
---|---|
author | Tang, Zifei Sun, Song Ji, Min Shi, Peng Wang, Yuhuan Huang, Zhiheng Huang, Ying |
author_facet | Tang, Zifei Sun, Song Ji, Min Shi, Peng Wang, Yuhuan Huang, Zhiheng Huang, Ying |
author_sort | Tang, Zifei |
collection | PubMed |
description | BACKGROUND: Very early-onset inflammatory bowel disease (VEOIBD) with interleukin-10 (IL10R) signaling deficiency usually requires enterostomy in patients who are refractory to traditional treatment. This study aimed to evaluate long-term outcomes after enterostomy for VEOIBD patients with IL10R signaling deficiency. METHODS: The medical records of all patients undergoing enterostomy for signaling deficiency were retrospectively assessed during 2012.1–2022.7 in a tertiary teaching hospital, Children’s Hospital of Fudan University, Shanghai, China. Data on disease history, diagnosis and details of enterostomy and stoma closure and follow-up were collected. Univariate and multivariate logistic regression analyses were used to evaluate the risk factors associated with the long-term outcome of delayed stoma closure. RESULTS: A total of 46 patients underwent an enterostomy, 19 who required emergency enterostomy and 27 with selective enterostomy. After ten years of follow-up, 35 patients underwent hematopoietic stem cell transplantation (HSCT), and 25 patients were alive after HSCT. The median timeframe between HSCT and stoma closure was 19.6 [15.9,26.2] months. Nineteen patients underwent stoma closure and had an average age of 3.9 ± 1.5 years; 6 patients were waiting for stoma closure. Based on a univariate logistic model, risk factors significantly associated with late stoma closure were age at enterostomy and age at HSCT. However, multivariate logistic regression showed no statistically significant factor associated with late stoma closure. There was no significant difference between the stoma closure group and delay closure group in the z scores of weight for age at follow up. CONCLUSIONS: This study determined the long-term outcomes after enterostomy for VEOIBD with interleukin-10 signaling deficiency. The appropriate time point of enterostomy and HSCT may improve quality of life in the long term. |
format | Online Article Text |
id | pubmed-10661559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106615592023-11-20 Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency Tang, Zifei Sun, Song Ji, Min Shi, Peng Wang, Yuhuan Huang, Zhiheng Huang, Ying BMC Gastroenterol Research BACKGROUND: Very early-onset inflammatory bowel disease (VEOIBD) with interleukin-10 (IL10R) signaling deficiency usually requires enterostomy in patients who are refractory to traditional treatment. This study aimed to evaluate long-term outcomes after enterostomy for VEOIBD patients with IL10R signaling deficiency. METHODS: The medical records of all patients undergoing enterostomy for signaling deficiency were retrospectively assessed during 2012.1–2022.7 in a tertiary teaching hospital, Children’s Hospital of Fudan University, Shanghai, China. Data on disease history, diagnosis and details of enterostomy and stoma closure and follow-up were collected. Univariate and multivariate logistic regression analyses were used to evaluate the risk factors associated with the long-term outcome of delayed stoma closure. RESULTS: A total of 46 patients underwent an enterostomy, 19 who required emergency enterostomy and 27 with selective enterostomy. After ten years of follow-up, 35 patients underwent hematopoietic stem cell transplantation (HSCT), and 25 patients were alive after HSCT. The median timeframe between HSCT and stoma closure was 19.6 [15.9,26.2] months. Nineteen patients underwent stoma closure and had an average age of 3.9 ± 1.5 years; 6 patients were waiting for stoma closure. Based on a univariate logistic model, risk factors significantly associated with late stoma closure were age at enterostomy and age at HSCT. However, multivariate logistic regression showed no statistically significant factor associated with late stoma closure. There was no significant difference between the stoma closure group and delay closure group in the z scores of weight for age at follow up. CONCLUSIONS: This study determined the long-term outcomes after enterostomy for VEOIBD with interleukin-10 signaling deficiency. The appropriate time point of enterostomy and HSCT may improve quality of life in the long term. BioMed Central 2023-11-20 /pmc/articles/PMC10661559/ /pubmed/37986047 http://dx.doi.org/10.1186/s12876-023-03051-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tang, Zifei Sun, Song Ji, Min Shi, Peng Wang, Yuhuan Huang, Zhiheng Huang, Ying Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
title | Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
title_full | Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
title_fullStr | Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
title_full_unstemmed | Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
title_short | Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
title_sort | long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661559/ https://www.ncbi.nlm.nih.gov/pubmed/37986047 http://dx.doi.org/10.1186/s12876-023-03051-4 |
work_keys_str_mv | AT tangzifei longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency AT sunsong longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency AT jimin longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency AT shipeng longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency AT wangyuhuan longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency AT huangzhiheng longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency AT huangying longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency |